Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Deutsche Health and Wellness Fund

+ Add to Watchlist

SCHLX:US

42.89 USD 0.65 1.49%

As of 09:29:30 ET on 01/30/2015.

Snapshot for Deutsche Health and Wellness Fund (SCHLX)

Year To Date: +1.97% 3-Month: +4.89% 3-Year: +28.46% 52-Week Range: 33.06 - 44.02
1-Month: +1.97% 1-Year: +25.49% 5-Year: +21.23% Beta vs MXWO: 0.94

Mutual Fund Chart for SCHLX

No chart data available.
  • SCHLX:US 42.89
  • 1M
  • 1Y
Interactive SCHLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SCHLX

Deutsche Health and Wellness Fund is an open-end fund incorporated in the USA. The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in the health care sector. This includes pharmaceuticals, biotechnology, medical products and supplies, and health care services.

Inception Date: 03-02-1998 Telephone: 1-800-730-1313
Managers: THOMAS E BUCHER / PETER BARSA
Web Site: www.fundsus.deutscheawm.com

Fundamentals for SCHLX

NAV (on 2015-01-30) 42.89
Assets (M) (on 2015-01-30) 365.80
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 50.00

Dividends for SCHLX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-12) 0.66
Dividend Yield (ttm) 7.67

Fees & Expenses for SCHLX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.77
Redemption Fee 2.00
12b1 Fee 0.00
Expense Ratio 1.09

Top Fund Holdings for SCHLX

Filing Date: 11/28/2014
Name Position Value % of Total
Actavis plc 49,574 13,415,220 3.648%
Gilead Sciences Inc 128,878 12,929,041 3.516%
Bristol-Myers Squibb Co 213,812 12,625,599 3.433%
Celgene Corp 107,467 12,217,923 3.322%
AbbVie Inc 167,793 11,611,276 3.157%
Merck & Co Inc 178,380 10,774,152 2.930%
Johnson & Johnson 96,238 10,417,764 2.833%
Amgen Inc 59,595 9,851,649 2.679%
Pfizer Inc 303,470 9,453,091 2.570%
Biogen Idec Inc 29,336 9,026,394 2.454%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil